The large language model GPT-4 compared to endocrinologist responses on initial choice of antidiabetic medication under conditions of clinical uncertainty
Flory JH, Ancker JS, Kim SYH, Kuperman G, et al.
Diabetes Care. Pub. online 9 Sep 2024.
Leggi
Breaking news
Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries
Li C, Bishop TRP, Imamura F, et al.
Lancet Diabetes Endocrinol. Pub. online 12 Sep 2024.
Leggi
Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID-19: Up to 40 months’ follow-up
Mehrotra-Varma S, Lu JY, Boparai MS, et al.
Diabetes Obes Metab. Pub. online 2 Sep 2024.
Leggi
Fracture risk revisited: Bone mineral density T-score and fracture risk in type 2 diabetes
Kafai Yahyavi S, Kristensen PL, Hjorthøj C, et al.
Diabetes Obes Metab. Pub. online 2 Sep 2024.
Leggi
The use of composite endpoints in cardiovascular outcome trials for diabetes: a review of 22 randomized clinical trials published since 2008
Kafai Yahyavi S, Kristensen PL, Hjorthøj C, et al.
Diabetes Obes Metab. Pub. online 2 Sep 2024.
Leggi
EMA: Direct healthcare professional communication (DHPC): Update on Ozempic (semaglutide) and Victoza (liraglutide): Supply shortage
02/09/2024
Leggi
FDA: Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings
05/09/2024
Leggi
Finerenone in heart failure with mildly reduced or preserved ejection fraction
Solomon SD, McMurray JJV, Vaduganathan M, et al.
N Engl J Med. Pub. online 1 Sep 2024.
Leggi
Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials
Wadden TA, Brown GK, Egebjerg C, et al.
JAMA Intern Med. Pub. online 3 Sep 2024.
Leggi